AFASAK

AFASAK

A primary prevention study comparing low-dose aspirin to warfarin anticoagulation in preventing thromboembolic phenomena (stroke, TIA, or embolic complications) of chronic atrial fibrillation.
Conclusion Thromboembolism was much lower with warfarin (2.0% per year) than with aspirin (5.5% per year) or placebo.